Leadership Team
Alan Greene
Chief Commercialization Officer
Alan Greene is a respiratory care professional with over 40 years of business development experience within academic hospitals and medical device companies, having led and developed clinical education, sales, and marketing teams in both domestic and foreign-held corporations. His love of education and focus on improving patient outcomes led him to Nellcor in 1988, at that time a startup medical device company, which subsequently was sold in 1998. Al spent the next 16 years at Fisher and Paykel Healthcare, US Operations, as head of Clinical Education, Marketing and Sales. He then made significant contributions to a series of successful startups in the Respiratory Disease Management and Sleep Spaces as Executive VP, Business Development and Chief Marketing Officer, most recently with Bleep Sleep. Mr. Greene actively serves on the Boards of Ataia Medical and SNAP-CPAP. Mr. Greene is a graduate of the SUNY System and a graduate of the UNC-CH Kenan-Flagler Executive Hospital Management Program.
​
LinkedIN: https://www.linkedin.com/in/alan-greene-rrt-0914556/
Emil Engels, MD
​Chief Medical Officer
Emil Engels, MD, MBA, is a healthcare CEO, board member, and advisor who blends clinical credibility with private-equity discipline to scale physician-led enterprises. A board-certified anesthesiologist, he has led large, multi-site teams and complex P&Ls, focusing on quality outcomes, labor efficiency, supply chain, volume growth, and revenue-cycle optimization. As Chief Executive Officer of Aligned Orthopedic Partners (2021–2024), he oversaw a platform approaching $100M in revenue across Maryland, Virginia, and Washington, D.C., achieving ~400% growth in providers, revenue, and EBITDA within three years, completing five acquisitions, expanding ancillaries (diagnostic imaging, PT, urgent care), and supporting two surgery centers. Earlier at MEDNAX, he managed 12 practices (800 providers; ~$260M NPSR) as President, Northeast Market, and as Division Medical Officer created division-wide clinical guidelines, dashboards, and quality measures, led a CMS-approved QCDR, and advanced ERAS and perioperative programs—turning a –$4M practice into a +$3M performer and stabilizing hospital relationships.
Dr. Engels currently serves as a Venture Capitalist with PhyCap Fund and as an Operating Partner with 74 North Capital, while advising Vault Advisors and participating in Invidia Capital Management’s executive network. He has held board roles at Brio Device and Monitor Mask, and serves on The College Foundation of the University of Virginia’s board. Professional leadership includes presidency of the Virginia Society of Anesthesiologists and consulting for North American Partners in Anesthesia.
An Echols Scholar at the University of Virginia (BA), Dr. Engels earned his MD from Yale and an MBA from the University of Tennessee (Haslam), and trained at Harvard’s Brigham and Women’s Hospital (residency and cardiac anesthesia fellowship).
​
LinkedIN: https://www.linkedin.com/in/emil-engels-md-mba-45750164/
Nam Trinh
Regulatory and Quality Affairs
Nam Trinh is the Head of Quality and Regulatory Affairs for Scopemed. In this role, he is responsible for overseeing the company's operational efficiency, managing the supply chain, and ensuring that all products meet stringent regulatory compliance standards necessary for market entry and sustained sales. This includes navigating the complex landscape of medical device regulations and securing necessary approvals.
Nam Trinh has served as the Vice President of Supply Chain and Compliance at Securisyn Medical, where he handled matters on regulatory affairs. He is a senior quality and engineering executive with extensive experience and successful leadership in Quality Management Systems within the global medical device industry.
His significant accomplishments include successfully spearheading key product developments and manufacturing from concept to market. This demonstrates his ability to guide medical devices through the entire product lifecycle, from initial idea to commercialization.
Mr. Trinh's core expertise and knowledge encompass a detailed understanding of FDA Quality System Regulation (QSR), ISO 13485 (Medical devices - Quality management systems - Requirements for regulatory purposes), and European medical device regulations. This comprehensive regulatory knowledge is critical for ensuring Scopemed's products meet the necessary compliance standards for global market entry and sustained sales. His background in quality and engineering leadership further ensures that operational efficiency and product quality are maintained throughout the supply chain.
Mr. Trinh holds a Bachelor of Science degree in Mechanical Engineering and a Masters of Business Administration (MBA) from the University of Colorado.
​
LinkedIn: https://www.linkedin.com/in/ntrinh1102/